Sartorius Aktiengesellschaft (SRT) - Total Liabilities
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has total liabilities worth €5.98 Billion EUR (≈ $6.99 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sartorius Aktiengesellschaft - Total Liabilities Trend (2013–2025)
This chart illustrates how Sartorius Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. See SRT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Sartorius Aktiengesellschaft Competitors by Total Liabilities
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Clearwater Analytics Holdings Inc
NYSE:CWAN
|
USA | $972.29 Million |
|
Shanghai Electric Power Co Ltd
SHG:600021
|
China | CN¥149.90 Billion |
|
Telekom Malaysia Bhd
KLSE:4863
|
Malaysia | RM23.84 Million |
|
Wan Hai Lines Ltd
TW:2615
|
Taiwan | NT$133.14 Billion |
|
Silergy Corp
TW:6415
|
Taiwan | NT$7.45 Billion |
|
Lottomatica Group SpA
NYSE:LOTMY
|
USA | $3.13 Billion |
|
STAG Industrial Inc
NYSE:STAG
|
USA | $3.40 Billion |
|
Flughafen Zurich
SW:FHZN
|
Switzerland | CHF2.42 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Sartorius Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Sartorius Aktiengesellschaft worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sartorius Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sartorius Aktiengesellschaft (2013–2025)
The table below shows the annual total liabilities of Sartorius Aktiengesellschaft from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €5.85 Billion ≈ $6.84 Billion |
-5.73% |
| 2024-12-31 | €6.21 Billion ≈ $7.25 Billion |
-11.20% |
| 2023-12-31 | €6.99 Billion ≈ $8.17 Billion |
+61.79% |
| 2022-12-31 | €4.32 Billion ≈ $5.05 Billion |
+8.57% |
| 2021-12-31 | €3.98 Billion ≈ $4.65 Billion |
+20.72% |
| 2020-12-31 | €3.30 Billion ≈ $3.85 Billion |
+86.89% |
| 2019-12-31 | €1.76 Billion ≈ $2.06 Billion |
+13.49% |
| 2018-12-31 | €1.55 Billion ≈ $1.82 Billion |
+4.18% |
| 2017-12-31 | €1.49 Billion ≈ $1.74 Billion |
+46.74% |
| 2016-12-31 | €1.02 Billion ≈ $1.19 Billion |
+28.23% |
| 2015-12-31 | €792.48 Million ≈ $926.50 Million |
+2.21% |
| 2014-12-31 | €775.37 Million ≈ $906.49 Million |
+6.06% |
| 2013-12-31 | €731.07 Million ≈ $854.70 Million |
-- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more